Nuclear Stock Face-Off: Is Oklo or NuScale Power the Better Buy Right Now?

The article compares Oklo and NuScale as small modular nuclear reactor plays tied to rising AI/data center power demand, with Oklo favored for its direct electricity-selling model and NuScale favored for regulatory certainty. Oklo lacks NRC approval for its reactor designs, while NuScale’s ENTRA1 partnership could support a 6 GW TVA project, potentially the largest SMR deployment in the U.S. The piece is primarily opinion-driven stock commentary rather than new operating data, so near-term market impact should be limited.

Analysis

The market is likely underappreciating that this is not just a reactor-vs-reactor debate; it is a business-model race between vertically integrated power delivery and capital-light licensing. If AI buildouts keep compressing decision cycles, the first company to offer a repeatable, financeable, on-site power stack will capture the highest-value customers, because downtime risk matters more than sticker price for data centers. That structurally favors the model with the cleanest permitting, financing, and interconnection path, not necessarily the best engineering story.

The second-order winner may be the infrastructure layer around the buildout: grid operators, EPCs, and component suppliers that get paid regardless of which reactor model wins. If deployment accelerates, demand will shift upstream into nuclear-grade forgings, specialized controls, switchgear, and large civil works, creating bottlenecks that could delay revenue recognition by 12-24 months even if orders are signed sooner. That means the near-term market may overprice “deal announcements” while underpricing schedule risk and working-capital intensity.

Regulatory optionality is the key asymmetry. The higher-risk name has more torque if it clears licensing milestones, but that same optionality makes it fragile to any delay in approval, financing, or customer conversion. The lower-risk path may be less exciting on headline growth, but it can compound through partner-led project finance and utility-scale procurement, which tends to be slower but more bankable.

Consensus seems to be treating AI power demand as linear; it is not. If hyperscalers slow capex or shift toward GPU efficiency gains, the urgency for bespoke behind-the-meter power weakens sharply, and these equities can de-rate fast because valuations are carrying multiple years of future deployment. The better contrarian setup is to own the route with clearer regulatory milestones and shorter funding gap, while fading the highest-beta story into hype spikes.

Key Decisions for Investors

• Long SMR / short OKLO as a 3-6 month relative-value pair: favor the name with clearer regulatory visibility and lower execution risk; target 15-25% spread compression if licensing remains the key gating item.
• For those seeking upside convexity, buy OKLO call spreads 6-12 months out only on pullbacks after project/news-driven spikes; the trade works if a single customer conversion re-rates the growth narrative, but stop-loss on any permitting delay headline.
• Add EQIX and META on weakness as indirect beneficiaries of any nuclear-power buildout narrative; they monetize AI demand immediately while reactor economics remain a longer-dated option.
• Avoid chasing headline strength in both names after partnership announcements; use event-driven entries only after confirming financing or regulatory milestones, since the market is likely to overvalue MOUs relative to bankable contracts.
• Monitor TVA-linked developments as a catalyst basket: if that project advances, consider a tactical long SMR with a 2-4 week horizon; if it stalls, expect nuclear multiples to compress across the group.